Victor Kim1, Huaqing Zhao2, Elizabeth Regan3, MeiLan K Han4, Barry J Make3, James D Crapo3, Paul W Jones5, Jeffrey L Curtis6, Edwin K Silverman7, Gerard J Criner2. 1. Lewis Katz School of Medicine at Temple University, Philadelphia, PA. Electronic address: victor.kim@tuhs.temple.edu. 2. Lewis Katz School of Medicine at Temple University, Philadelphia, PA. 3. National Jewish Health, Denver, CO. 4. University of Michigan Health Care System, Ann Arbor, MI. 5. St. George's Hospital Medical School, London, UK. 6. VA Ann Arbor Healthcare System, Ann Arbor, MI. 7. Brigham and Women's Hospital, Boston, MA.
Abstract
BACKGROUND: Chronic bronchitis (CB) increases risk of COPD exacerbations. We have shown that the St. George's Respiratory Questionnaire (SGRQ) CB definition identifies patients with a similar clinical phenotype as classically defined CB. Whether the SGRQ CB definition is a predictor of future COPD exacerbations is unknown. METHODS: We analyzed 7,557 smokers with normal spirometry and Global Initiative for Chronic Obstructive Lung Disease stage 1-4 COPD in the Genetic Epidemiology of COPD study with longitudinal follow-up data on exacerbations. Subjects were divided into classic CB+ or classic CB-, using the classic definition. In addition, subjects were divided into SGRQ CB+ or SGRQ CB-. Exacerbation frequency and severe exacerbation frequency were determined in each group. Multivariable linear regressions were performed for exacerbation frequency with either classic CB or SGRQ CB and relevant covariates. RESULTS: There were 1,434 classic CB+ subjects and 2,290 SGRQ CB+ subjects. The classic CB+ group had a greater exacerbation frequency compared with the classic CB- group (0.69 ± 1.26 vs 0.36 ± 0.90 exacerbations per patient per year; P < .0001) and a greater severe exacerbation frequency (0.26 ± 0.74 vs 0.13 ± 0.46 severe exacerbations per patient per year; P < .0001). There were similar differences between the SGRQ CB+ and SGRQ CB- groups. In multivariable analysis, both SGRQ CB and classic CB were independent predictors of exacerbation frequency, but SGRQ CB had a higher regression coefficient. In addition, SGRQ CB was an independent predictor of severe exacerbation frequency whereas classic CB was not. CONCLUSIONS: The SGRQ CB definition identified more subjects at risk for future exacerbations than the classic CB definition. SGRQ CB was at least a similar if not better predictor of future exacerbations than classic CB.
BACKGROUND:Chronic bronchitis (CB) increases risk of COPD exacerbations. We have shown that the St. George's Respiratory Questionnaire (SGRQ) CB definition identifies patients with a similar clinical phenotype as classically defined CB. Whether the SGRQ CB definition is a predictor of future COPD exacerbations is unknown. METHODS: We analyzed 7,557 smokers with normal spirometry and Global Initiative for Chronic Obstructive Lung Disease stage 1-4 COPD in the Genetic Epidemiology of COPD study with longitudinal follow-up data on exacerbations. Subjects were divided into classic CB+ or classic CB-, using the classic definition. In addition, subjects were divided into SGRQ CB+ or SGRQ CB-. Exacerbation frequency and severe exacerbation frequency were determined in each group. Multivariable linear regressions were performed for exacerbation frequency with either classic CB or SGRQ CB and relevant covariates. RESULTS: There were 1,434 classic CB+ subjects and 2,290 SGRQ CB+ subjects. The classic CB+ group had a greater exacerbation frequency compared with the classic CB- group (0.69 ± 1.26 vs 0.36 ± 0.90 exacerbations per patient per year; P < .0001) and a greater severe exacerbation frequency (0.26 ± 0.74 vs 0.13 ± 0.46 severe exacerbations per patient per year; P < .0001). There were similar differences between the SGRQ CB+ and SGRQ CB- groups. In multivariable analysis, both SGRQ CB and classic CB were independent predictors of exacerbation frequency, but SGRQ CB had a higher regression coefficient. In addition, SGRQ CB was an independent predictor of severe exacerbation frequency whereas classic CB was not. CONCLUSIONS: The SGRQ CB definition identified more subjects at risk for future exacerbations than the classic CB definition. SGRQ CB was at least a similar if not better predictor of future exacerbations than classic CB.
Authors: Maria Montes de Oca; Ronald J Halbert; Maria Victorina Lopez; Rogelio Perez-Padilla; Carlos Tálamo; Dolores Moreno; Adrianna Muiño; José Roberto B Jardim; Gonzalo Valdivia; Julio Pertuzé; Ana Maria B Menezes Journal: Eur Respir J Date: 2012-01-26 Impact factor: 16.671
Authors: P Pallasaho; B Lundbäck; S L Läspä; E Jönsson; J Kotaniemi; A R Sovijärvi; L A Laitinen Journal: Respir Med Date: 1999-11 Impact factor: 3.415
Authors: MeiLan K Han; Nabihah Tayob; Susan Murray; Mark T Dransfield; George Washko; Paul D Scanlon; Gerard J Criner; Richard Casaburi; John Connett; Stephen C Lazarus; Richard Albert; Prescott Woodruff; Fernando J Martinez Journal: Am J Respir Crit Care Med Date: 2014-06-15 Impact factor: 21.405
Authors: Victor Kim; Alice L Sternberg; George Washko; Barry J Make; Meilan K Han; Fernando Martinez; Gerard J Criner Journal: COPD Date: 2013-08-26 Impact factor: 2.409
Authors: Radmila Choate; Cara B Pasquale; Nereida A Parada; Valentin Prieto-Centurion; Richard A Mularski; Barbara P Yawn Journal: Chronic Obstr Pulm Dis Date: 2020-01
Authors: Eleanor M Dunican; Brett M Elicker; Travis Henry; David S Gierada; Mark L Schiebler; Wayne Anderson; Igor Barjaktarevic; R Graham Barr; Eugene R Bleecker; Richard C Boucher; Russell Bowler; Stephanie A Christenson; Alejandro Comellas; Christopher B Cooper; David Couper; Gerard J Criner; Mark Dransfield; Claire M Doerschuk; M Bradley Drummond; Nadia N Hansel; MeiLan K Han; Annette T Hastie; Eric A Hoffman; Jerry A Krishnan; Stephen C Lazarus; Fernando J Martinez; Charles E McCulloch; Wanda K O'Neal; Victor E Ortega; Robert Paine; Stephen Peters; Joyce D Schroeder; Prescott G Woodruff; John V Fahy Journal: Am J Respir Crit Care Med Date: 2021-04-15 Impact factor: 21.405
Authors: Surya P Bhatt; Sandeep Bodduluri; Abhilash S Kizhakke Puliyakote; Elizabeth C Oelsner; Arie Nakhmani; David A Lynch; Carla G Wilson; Spyridon Fortis; Victor Kim Journal: Thorax Date: 2021-01-06 Impact factor: 9.139
Authors: Justin L Garner; Tawimas Shaipanich; Jorine E Hartman; Christopher M Orton; Cielito Caneja; Karin Klooster; John Thornton; Don D Sin; Dirk-Jan Slebos; Pallav L Shah Journal: Eur Respir J Date: 2020-12-17 Impact factor: 16.671
Authors: Victor Kim; Stephanie Jeong; Huaqing Zhao; Mehmet Kesimer; Richard C Boucher; J Michael Wells; Stephanie A Christenson; MeiLan K Han; Mark Dransfield; Robert Paine; Christopher B Cooper; Igor Barjaktarevic; Russell Bowler; Jeffrey L Curtis; Robert J Kaner; Sarah L O'Beirne; Wanda K O'Neal; Stephen I Rennard; Fernando J Martinez; Prescott G Woodruff Journal: Sci Rep Date: 2020-11-18 Impact factor: 4.379
Authors: Marni Stott-Miller; Hana Müllerová; Bruce Miller; Maggie Tabberer; Céline El Baou; Tom Keeley; Fernando J Martinez; Meilan Han; Mark Dransfield; Nadia N Hansel; Christopher B Cooper; Prescott Woodruff; Victor E Ortega; Alejandro P Comellas; Robert Paine Iii; Richard E Kanner; Wayne Anderson; M Bradley Drummond; Victor Kim; Ruth Tal-Singer; Aili L Lazaar Journal: Int J Chron Obstruct Pulmon Dis Date: 2020-10-13